Psychiatric Aspects of Parkinson’s Disease in Animal Models of Deep Brain Stimulation of the Subthalamic Nucleus

  • S. K. H. Tan
  • H. Hartung
  • V. Visser-Vandewalle
  • T. Sharp
  • Y. Temel


It is well established that deep brain stimulation (DBS) of the subthalamic nucleus (STN) has beneficial effects on motor symptoms of Parkinson’s disease (PD). Unfortunately, these can be overshadowed by psychiatric side effects, including depression and suicide. The underlying mechanism is unknown, but it is generally believed that low mood is related to a dysfunction of the serotonin (5-hydroxytryptamine; 5-HT) system. Recent animal experiments have demonstrated that bilateral STN DBS with clinically relevant parameters (130 Hz, 60 μs, 100–200 μA) inhibits 5-HT neurotransmission in the brain. In anaesthetized rats bilateral STN DBS caused a significant inhibition of 5-HT neuronal activity in the dorsal raphe nucleus (DRN). Moreover, both unilateral and bilateral STN DBS inhibited 5-HT release in the forebrain of anaesthetized and freely moving rats. A direct STN projection to the DRN does not exist, making a multisynaptic pathway most likely. On the basis of increased expression of c-Fos, a marker of neuronal activity, it was found that the medial prefrontal cortex and lateral habenula potentially mediate the inhibitory effect of STN DBS on the DRN 5-HT system. Previously these two brain regions have been extensively described in inhibitory control of DRN 5-HT neurons. Behavioural evaluation showed that bilateral STN DBS also induced depressive-like behaviour in the forced swim test and increased interaction in the social interaction test. Interestingly, depressive-like behaviour could be prevented by treatment with a 5-HT reuptake inhibitor. Thus, STN DBS induced inhibition of 5-HT transmission via a multisynaptic anatomical pathway may underlie the development of psychiatric complications such as depression. STN DBS treated patients with these symptoms may benefit from drug treatment focusing on 5-HT transmission.


Deep Brain Stimulation Forced Swim Test Dorsal Raphe Nucleus Mood Regulation Social Interaction Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Appleby BS et al (2007) Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years’ experience. Mov Disord 22:1722–1728PubMedCrossRefGoogle Scholar
  2. Asberg M et al (1976) “Serotonin depression”—a biochemical subgroup within the affective disorders? Science 191:478–480PubMedCrossRefGoogle Scholar
  3. Cannon DM et al (2007) Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biol Psychiatry 62:870–877PubMedCrossRefGoogle Scholar
  4. Carta M et al (2007) Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 130:1819–1833PubMedCrossRefGoogle Scholar
  5. Cryan JF et al (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238–245PubMedCrossRefGoogle Scholar
  6. Deuschl G et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908PubMedCrossRefGoogle Scholar
  7. Groenewegen HJ, Berendse HW (1990) Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J Comp Neurol 294:607–622PubMedCrossRefGoogle Scholar
  8. Hartung H et al (2011) High-frequency stimulation of the subthalamic nucleus inhibits the firing of juxtacellular labelled 5-HT-containing neurones. Neuroscience 186:135–145PubMedCrossRefGoogle Scholar
  9. Houeto JL et al (2000) Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 57:461–465PubMedCrossRefGoogle Scholar
  10. Krack P et al (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349:1925–1934PubMedCrossRefGoogle Scholar
  11. Kumar R et al (1999) Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology 53:561–566PubMedCrossRefGoogle Scholar
  12. Limousin P et al (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345:91–95PubMedCrossRefGoogle Scholar
  13. Navailles S et al (2010) High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson’s disease. J Neurosci 30:2356–2364PubMedCrossRefGoogle Scholar
  14. Peyron C et al (1998) Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 82:443–468PubMedCrossRefGoogle Scholar
  15. Pollak P et al (1993) Effects of the stimulation of the subthalamic nucleus in Parkinson disease. Rev Neurol (Paris) 149:175–176Google Scholar
  16. Rodriguez MC et al (1998) The subthalamic nucleus and tremor in Parkinson’s disease. Mov Disord 13(Suppl 3):111–118PubMedGoogle Scholar
  17. Rylander D et al (2010) Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol 68:619–628PubMedCrossRefGoogle Scholar
  18. Sharp T et al (2007) Important messages in the ‘post’: recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci 28:629–636PubMedCrossRefGoogle Scholar
  19. Steinbusch HW (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 6:557–618PubMedCrossRefGoogle Scholar
  20. Takeshita S et al (2005) Effect of subthalamic stimulation on mood state in Parkinson’s disease: evaluation of previous facts and problems. Neurosurg Rev 28:179–86 (discussion 187)Google Scholar
  21. Tan SK et al (2012) A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission. Exp Neurol 233:145–53Google Scholar
  22. Tan S et al (2010) Experimental deep brain stimulation in animal models. Neurosurgery 67:1073–1079 (discussion 1080)Google Scholar
  23. Tan SK et al (2011a) Serotonin-dependent depression in Parkinson’s disease: a role for the subthalamic nucleus? Neuropharmacology 61:387–399PubMedCrossRefGoogle Scholar
  24. Tan SK et al (2011b) High frequency stimulation of the subthalamic nucleus increases c-fos immunoreactivity in the dorsal raphe nucleus and afferent brain regions. J Psychiatr Res 45:1307–1315PubMedCrossRefGoogle Scholar
  25. Taylor MJ et al (2006) Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 63:1217–1223PubMedCrossRefGoogle Scholar
  26. Temel Y et al (2005) The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog Neurobiol 76:393–413PubMedCrossRefGoogle Scholar
  27. Temel Y et al (2006) Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 12:265–272PubMedCrossRefGoogle Scholar
  28. Temel Y et al (2007) Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci U S A 104:17087–17092PubMedCrossRefGoogle Scholar
  29. Tommasi G et al (2008) Transient acute depressive state induced by subthalamic region stimulation. J Neurol Sci 273:135–138PubMedCrossRefGoogle Scholar
  30. Voon V et al (2008) A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain 131:2720–2728PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • S. K. H. Tan
    • 1
    • 2
  • H. Hartung
    • 3
  • V. Visser-Vandewalle
    • 1
    • 2
  • T. Sharp
    • 3
  • Y. Temel
    • 1
    • 2
  1. 1.Department of NeuroscienceMaastricht UniversityMaastrichtThe Netherlands
  2. 2.Department of NeurosurgeryMaastricht University Medical CentreMaastrichtThe Netherlands
  3. 3.Department of PharmacologyUniversity of OxfordOxfordUK

Personalised recommendations